X4 Pharmaceuticals Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.22

+0.17 (+4.20%)

As of Jun 21, 10:27 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +573.5% upside

Low Target $21.41

Average Target $28.42

High Target $38.37

Current Price $4.22

Current
$4.22

Target
$28.42

$21.41 $28.42 avg $38.37

Scenario Analysis

Bear Case

$21.41

407.3%

Low target

Base Case

$28.42

+573.5%

Avg target

Bull Case

$38.37

+809.2%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$4.83

-12.6% from high

52-Week Low

$1.35

+212.6% from low

Target vs 52W High

$28.42

+488.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.7%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+189.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-7.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.0%